Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.257
-0.021 (-7.62%)
Apr 29, 2026, 9:56 AM EDT - Market open

Mereo BioPharma Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
426654232388174
Upgrade
Market Cap Growth
-85.54%-87.77%67.64%269.38%-49.64%-28.05%
Upgrade
Enterprise Value
3184682821750
Upgrade
Last Close Price
0.280.423.502.310.751.60
Upgrade
PE Ratio
-----10.09
Upgrade
PS Ratio
88.09132.62-32.34-3.52
Upgrade
PB Ratio
1.081.628.896.401.701.46
Upgrade
P/TBV Ratio
1.091.648.996.541.702.02
Upgrade
EV/Sales Ratio
6.5136.02-28.17-1.02
Upgrade
Debt / Equity Ratio
0.010.010.110.120.300.19
Upgrade
Net Debt / Equity Ratio
-1.00-1.00-1.04-1.02-1.03-0.88
Upgrade
Net Debt / EBITDA Ratio
1.081.081.401.941.013.72
Upgrade
Net Debt / FCF Ratio
1.321.321.932.441.0813.43
Upgrade
Asset Turnover
0.010.01-0.14-0.39
Upgrade
Quick Ratio
9.999.995.286.452.897.66
Upgrade
Current Ratio
10.4710.475.406.723.097.92
Upgrade
Return on Equity (ROE)
-82.21%-82.21%-77.58%-57.81%-53.63%34.85%
Upgrade
Return on Assets (ROA)
-39.41%-39.41%-39.99%-23.57%-28.67%-13.82%
Upgrade
Return on Invested Capital (ROIC)
-----825.95%-
Upgrade
Return on Capital Employed (ROCE)
-92.70%-92.70%-73.10%-47.60%-99.40%-18.40%
Upgrade
Earnings Yield
-95.08%-63.15%-7.98%-9.11%-48.22%9.91%
Upgrade
FCF Yield
-70.36%-46.74%-6.06%-6.54%-55.78%-4.50%
Upgrade
Buyback Yield / Dilution
-7.77%-7.77%-12.16%-9.33%-8.63%-63.82%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.